🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Johnson & Johnson says new tests show no asbestos in Johnson's Baby Powder

Published 12/03/2019, 09:13 PM
© Reuters. Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York
JNJ
-

By Sanjana Shivdas and Carl O'Donnell

(Reuters) - Johnson & Johnson (NYSE:JNJ) said on Tuesday that recent tests showed that Johnson's Baby Powder was free of asbestos, after U.S. Food and Drug Administration investigations reported trace amounts of the material in the product earlier this year.

A total of 155 tests were conducted by two different third-party labs using four different testing methods on samples from the same bottle tested by the FDA's contracted lab, the company said.

The tests are the latest effort by J&J to prove the safety of its widely used consumer product after the test by the FDA prompted J&J to undertake a nationwide recall of one lot of Johnson's Baby Powder in October.

The FDA was not immediately available for comment. However, in response to an October announcement from J&J that a smaller number of independent tests also found no asbestos, the regulatory agency said it stood by its findings.

The different test outcomes could have resulted from the fact that contaminants are not uniformly dispersed throughout talc and there is no standard test for asbestos in talc, FDA officials told Reuters in October.

Tests conducted by the third-party labs showed asbestos was not present in the single bottle that the FDA's contracted lab had tested, nor was it present in retained samples of the finished lot from which the bottle was produced, the company said on Tuesday.

The company said its investigation concluded that the most probable root causes for the FDA's reported results were either test sample contamination or analyst error at the lab, or both.

In October, J&J recalled around 33,000 bottles of baby powder in the United States after the FDA said it had found trace amounts of asbestos in samples taken from a bottle purchased online.

The voluntary recall was limited to one lot of Johnson's Baby Powder produced and shipped in the United States in 2018, the company said at the time.

That move marked the first time the company recalled its baby powder for possible asbestos contamination, and the first time U.S. regulators have announced a finding of asbestos in the product. Asbestos is a known carcinogen that has been linked to deadly mesothelioma.

The recall was the latest blow to the more than 130-year-old U.S. healthcare conglomerate that is facing thousands of lawsuits over a variety of products, including baby powder, opioids, medical devices and the antipsychotic Risperdal.

© Reuters. Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York

J&J faces more than 15,000 lawsuits from consumers claiming its talc products, including Johnson's Baby Powder, caused their cancer.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.